PAR 1.96% 25.0¢ paradigm biopharmaceuticals limited..

Interview with a FDA Process expert..., page-43

  1. 588 Posts.
    lightbulb Created with Sketch. 134

    Thanks for the reply and awaiting the SAS results with anticipation, but was referring to the P3 participants.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.